Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome
2022; Lippincott Williams & Wilkins; Volume: 41; Issue: 4 Linguagem: Inglês
10.1097/inf.0000000000003449
ISSN1532-0987
AutoresShana Godfred‐Cato, Joseph Y. Abrams, Neha Balachandran, Preeti Jaggi, Kaitlin Jones, Christina A. Rostad, Austin Lu, Lucie Fan, Aysha Jabbar, Evan J. Anderson, Carol Kao, David A. Hunstad, Robert B. Rosenberg, Marc J. Zafferani, Kaleo Ede, Wassim Ballan, Federico R. Laham, Yajira Beltran, Bobbi Bryant, Lu Meng, Teresa A. Hammett, Matthew E. Oster, Sapna Bamrah Morris, Ermias D. Belay,
Tópico(s)Mechanical Circulatory Support Devices
ResumoDistinguishing multisystem inflammatory syndrome in children (MIS-C) from coronavirus disease 2019 (COVID-19), Kawasaki disease (KD), and toxic shock syndrome (TSS) can be challenging. Because clinical management of these conditions can vary, timely and accurate diagnosis is essential.
Referência(s)